Evaxion Biotech A/S - ADR

NASDAQ:EVAX   2:39:46 PM EDT
8.15
-0.06 (-0.73%)
Other Pre-Announcement

Evaxion Biotech Announces Q2 2021 Financial Results And Provides Business Update

Published: 08/12/2021 10:47 GMT
Evaxion Biotech A/S - ADR (EVAX) - Evaxion Biotech Announces Q2 2021 Financial Results and Provides Business Update.
Q2 Loss per Share $0.36.
Q2 Earnings per Share Estimate $-0.29 -- Refinitiv Ibes Data (analyst estimates).
Current Cash Position of $18.8 Million is Expected to Be Sufficient to Fund Key Clinical Programs Into 2022.